Abstract:Discovering small-molecule chemical probes of protein function has great potential to elucidate biological pathways and to provide early-stage proof-of-concept for target validation. Discovery of such probes therefore underpins many of the chemical biology and drug discovery efforts in both academia and the pharmaceutical industry. The process generally begins with screening small molecules to identify bona fide "hits" that bind non-covalently to a target protein. This chapter is concerned with the application of biophysical and structural techniques to small-molecule ligand screening, and with the validation of hits from both structural (binding mode) and energetic (binding affinity) stand-points. The methods discussed include differential scanning fluorimetry (thermal shift), fluorescence polarization (FP), surface plasmon resonance, ligand-observed NMR spectroscopy, isothermal titration calorimetry, and protein X-ray crystallography. The principles of these techniques and the fundamental nature of the observables used to detect macromolecule-ligand binding are briefly outlined. The practicalities, advantages, and disadvantages of each technique are described, particularly in the context of detecting weak affinities, as relevant to fragment screening. Fluorescence-based methods, which offer an attractive combination of high throughput and low cost are discussed in detail. It is argued that applying a combination of different methods provides the most robust and effective way to identify high-quality starting points for follow-up medicinal chemistry and to build structure-activity relationships that better inform effective development of high-quality, cell-active chemical probes by structure-based drug design.

Small Bioactive Molecules Designed to Be Probes As Baits "fishing Out" Cellular Targets: Finding the Fish in the Proteome Sea

[The Application of Small Molecule Bioactive Probes in the Identification of Cellular Targets].

Identifying the Cellular Targets of Bioactive Small Molecules with Activity-Based Probes.

Methods to Profile the Macromolecular Targets of Small Compounds.

Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification

Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics

Identifying The Proteins To Which Small-Molecule Probes And Drugs Bind In Cells

Chemical Proteomics to Identify Molecular Targets of Small Compounds

Exploiting Chemical Probes for Identifying Drug Target Proteins

Identifying cellular targets of small-molecule probes and drugs with biochemical enrichment and SILAC.

Chemical proteomic mapping of reversible small molecule binding sites in native systems

Proteome interrogation using nanoprobes to identify targets of a cancer-killing molecule.

Activity-based Proteomic Profiling: the Application of Photoaffinity Probes in the Target Identification of Bioactive Molecules

Chemoproteomics and Chemical Probes for Target Discovery

Recent Advances in Target Identification by Natural Product Based Chemical Probes

Proteomic methods for drug target discovery

Progress of methodology for identifying target protein of natural active small molecules

Label-free target protein characterization for small molecule drugs: recent advances in methods and applications

Advances of validation of bioactive small molecule targets

Biophysical screening for the discovery of small-molecule ligands

Tetrazole-Based Probes for Integrated Phenotypic Screening, Affinity-Based Proteome Profiling, and Sensitive Detection of a Cancer Biomarker.